IQ

Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

ARKG vs PBPH: Holdings Overlap & Returns

Share
Share on XDownload as PDF

ARKG and PBPH hold 6% of their weight in the same names.

askIQ about this page

askIQ about ARKG and PBPH

Net assets: $2.1bn on Nov 2, 2026 for ARK Genomic Revolution ETF, and $952m on Jul 31, 2026 for Portfolio Building Block World Pharma and Biotech Index ETF.

ARKG on its own →PBPH on its own →
At a glance
4.6%
ARKG in the S&P 500
59.2%
PBPH in the S&P 500
+68.4%
ARKG total return, 1 year
+27.0%
PBPH total return, since launch, Nov 25, 2025
ARKG · 1 year to Nov 4, 2026 95% of its weight is outside the S&P 500
95% of its weight is outside the S&P 5005% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.5%95%inof its weight outside the S&P 500active share 99% · top ten 59% of the fund · 35 holdings as published by its issuer for Nov 2, 2026 · Nasdaq-100: 0% in95% of its weight is outside the S&P 5005% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.5%95%5% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · Nasdaq-100: 0% in

5% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.

PBPH · 6 months to Nov 4, 2026 41% of its weight is outside the S&P 500
41% of its weight is outside the S&P 50059% of PBPH's weight is in S&P 500 companies and 41% is outside the index. Holdings as of Jul 31, 2026.59%41%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 95% · top ten 62% of the fund · 53 holdings as filed for Jul 31, 2026 · Nasdaq-100: 14% in41% of its weight is outside the S&P 50059% of PBPH's weight is in S&P 500 companies and 41% is outside the index. Holdings as of Jul 31, 2026.59%41%in the S&P 500outsideactive share 95% · Nasdaq-100: 14% in

59% of PBPH's weight is in S&P 500 companies and 41% is outside the index. Holdings as of Jul 31, 2026.

Pair scorecard

PBPH costs 0.62 points a year less.

ARKG vs PBPH: Holdings Overlap & Returns
MeasureARKGPBPH
Return
Total return, 1 year+68.4%not published
Drawdown
Below its all-time high55.5%, high on Jan 20, 2021
Benchmark
What it tracksGenomics and gene editingBiotech
Cost and size
Expense ratio0.75%0.13%
Net assets, ARKG as of Nov 2, 2026 and PBPH as of Jul 31, 2026$2.1bn$952m
Active share vs the S&P 50098%95%
Holdings
Holdings in common6%
Top ten holdings, share of the fund58%62%

Method

What they share

6%

By the books each fund has filed, ARKG and PBPH hold 6% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Nov 2, 2026.

0 half 100%

half

6% in common

Positions both hold · largest shared weight first ARKG PBPH
ELI LILLY & CO 4.59% 15.20%
NATERA INC 4.67% 0.85%
ILLUMINA INC 4.26% 0.72%
IONIS PHARMACEUTICALS INC 1.79% 0.18%
Only in one fund ↓
Only in ARKG
TEMPUS AI INC-CL A 9.85%
10X GENOMICS INC-CLASS A 7.52%
TWIST BIOSCIENCE CORP 7.42%
CRISPR THERAPEUTICS AG 5.48%
GUARDANT HEALTH INC 5.13%
ABSCI CORP 5.08%
CAREDX INC 4.50%
BEAM THERAPEUTICS INC 3.84%
Only in PBPH
JOHNSON & JOHNSON 9.66%
ABBVIE INC 6.94%
MERCK & COMPANY INC 5.04%
ROCHE HOLDING AG 4.74%
AMGEN INC 4.63%
NOVARTIS AG 4.47%
ASTRAZENECA PLC 3.90%
GILEAD SCIENCES INC 3.77%
Check overlap with more funds →

Window by window

Window by window: ARKG vs PBPH: Holdings Overlap & Returns
Total return
WindowARKGPBPH
3 months+20.5%+16.2%
6 months+60.0%+25.6%
1 year+68.4%–
3 years+90.8%–
Since launchNot the same days: ARKG Oct 2014 · PBPH Nov 2025+164.2%+27.0%

– means no data for this window. Open this comparison in the app →

Side by side

ARKG ARK Genomic Revolution ETF · Holds 35 stocks in genomics and gene editing, 5% of its weight in S&P 500 companies PBPH Portfolio Building Block World Pharma and Biotech Index ETF · Holds 53 stocks in biotech, 59% of its weight in S&P 500 companies
Issuer ARK Portfolio Building Block
Theme Genomics and gene editing Biotech
In the S&P 500 4.6% 59.2%
Active share vs the S&P 500 98.5% 95.0%
In the Nasdaq-100 0.0% 13.6%
Holdings 35 53
Top ten, share of the fund 58.5% 61.9%
Expense ratio 0.75% 0.13%
Fee for the differing part 0.76% 0.14%
Total return, 1 year +68.4% +27.0% (since launch, Nov 25, 2025)
vs its benchmark not measured not measured
Below its high −55.5% 0.0%
Net assets, ARKG as of Nov 2, 2026 and PBPH as of Jul 31, 2026 $2.1bn $952m

As of Nov 4, 2026. Source: ETFIQ.

6% of the two portfolios are the same securities at the same weight.

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
ARKG

By weight, 5% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 58% of the fund across 35 positions, as published by its issuer for Nov 2, 2026. Over the year to Nov 4, 2026 the fund returned +68.4% with distributions reinvested. It sits 55.5% below its all-time high of Jan 20, 2021.

PBPH

By weight, 59% of PBPH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 95%. The top ten holdings are 62% of the fund across 53 positions, as filed for Jul 31, 2026. Since it first traded on Nov 25, 2025 the fund returned +27.0% with distributions reinvested.

Questions people ask

Do ARKG and PBPH hold the same stocks?
By their latest filings, 6% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, ARKG or PBPH?
ARKG has 5% of its weight in S&P 500 names and PBPH has 59%, so ARKG differs more from the index.
Which is cheaper, ARKG or PBPH?
ARKG charges 0.75% a year and PBPH charges 0.13%, so PBPH is cheaper. Fees come from each fund's prospectus.
Other comparisons
ARKG vs PBEARKG vs FBTARKG vs IBBQARKG vs XBIPBPH vs GNOMPBPH vs GNMXPBPH vs IDNAPBPH vs XBI
Where to next
All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →ARKG on its own →PBPH on its own →ARKG holdings →PBPH dividend history →PBPH holdings →Method →Standards and sources →
Sources and dates
ARKG filings on SEC EDGAR ↗
ARKG prospectus with the expense ratio (SEC) ↗
ARK page for ARKG ↗
PBPH filings on SEC EDGAR ↗
PBPH prospectus with the expense ratio (SEC) ↗
Portfolio Building Block page for PBPH ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, ARKG against PBPH, data as of Nov 4, 2026. https://etfiq.com/compare/themes/arkg-vs-pbph

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.